STAR Apollo™ Mapping System
Computer, Diagnostic, Programmable. 510(k) K263380, from Rhythm AI, Ltd. (London, GB). Product code DQK, class 2.
As of Nov 18, 2026, K263380 is an FDA 510(k) held by Rhythm AI, Ltd., substantially equivalent on Oct 23, 2026 after 29 days, with no recalls tied to it in FDA's recall database.
- Review time: 29 days
- Recalls: 0
Indications for use
As the 510(k) summary states them, read from FDA's summary PDFSTAR Apollo™ Mapping System assists users in the interpretation and manual annotation of 3D anatomical and electrical maps of human atria using data from multipolar, intracardiac, atrial, electrograms during atrial fibrillation.
Predicate devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- STAR Apollo™ Mapping SystemK253733 · Rhythm AI, Ltd. · Dec 19, 2025
Other DQK clearances
The newest 510(k)s for the same product code; their median review was 147 days; see every DQK device- Merge Hemo (Model RCSV2 (v11.3))K262171 · Merge Healthcare Incorporated · Nov 5, 2026
- Vivo (9002)K261886 · Catheter Precision, Inc. · Oct 30, 2026
- PulseAPI SmartWatchK254226 · PulseAI, Ltd. · Oct 27, 2026
- Intra-Operative Positioning System (IOPS) and IOPS Visionary SystemK263016 · Centerline Biomedical · Oct 1, 2026
- S-Patch CardioAIK254255 · Wellysis Corp. · Sep 25, 2026
- EnSite™ X EP SystemK261729 · Abbott Medical · Sep 17, 2026
- AVVIGO™+ Multi-Modality Guidance SystemK253692 · Boston Scientific · Aug 21, 2026
- Affera Integrated Mapping SystemK262005 · Medtronic, Inc. · Aug 21, 2026
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Sep 24, 2026
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.1425
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files